News

Lehigh Valley Cheers a New Era of Manufacturing as Lilly Breaks Ground

Published Tuesday, November 17, 2026
by Nicole Radzievich Mertz and Paul Muschick

 

In the Lehigh Valley, manufacturers have fans. 

Gov. Josh Shapiro got a reminder recently when a mention of Eli Lilly and Company’s investment prompted a cheer from the back of a crowd he was speaking to: “Yeah, Lilly!”

At the recent groundbreaking for the company’s $3.5 billion pharmaceutical manufacturing campus, Lehigh Valley Economic Development Corporation President & CEO Don Cunningham explained the enthusiasm.

Living in the shadows of Philadelphia and New York, he said, the Lehigh Valley may never have a major league sports team, so we cheer for our manufacturers, who are global icons. 

“We cheer for Mack Trucks, Crayola crayons, and Martin Guitar,” Cunningham said to an applauding audience of more than 100 at the groundbreaking in Upper Macungie Township on Nov. 12. “Now, we cheer for Lilly.”

With the largest economic development project in Lehigh Valley history, Lilly is giving the Lehigh Valley a new reason to cheer: 850 high-paying jobs, a projected $14 billion economic impact, and a place at the forefront of manufacturing next-generation obesity medicines.

Lilly Chair & CEO David Ricks joined Shapiro, Cunningham, and other dignitaries at the groundbreaking, taking ceremonial shovels full of soil to mark a new chapter in a region long defined by what it makes.

“This site will be one of the most technically advanced, not just in Lilly, but in the industry,” Ricks said. “It will be a source of good jobs for this region, and most importantly a source for medicines made in Pennsylvania for patients here and around the world.”

By 2031, Lilly Lehigh Valley will be producing the next generation of GLP-1 injectable medicines and devices that are revolutionizing health care and improving the quality of life for millions of people.

Near the Interstate 78/Route 100 cloverleaf in Upper Macungie, Lilly will join an industrial cluster anchored by companies including Nokia, Boston Beer Co., and soon, Chobani’s $1.2 billion production facility.

Lehigh Valley is one of the Top 15% of manufacturing markets in the U.S., based on Gross Domestic Product. More than 700 companies collectively produce $9 billion in output annually. That represents 16% of the region’s GDP. Nationally, manufacturing is 11% of GDP.

With investments by Lilly and others, life sciences is a growing part of that production.

Lilly is the largest life sciences investment in state history. In addition to the 850 permanent jobs, about 2,000 construction jobs are anticipated.

“This is a generational project,” Shapiro said. “Lilly could have chosen anywhere in the United States, really anywhere across the globe. But they chose to plant their flag right here in the Commonwealth of Pennsylvania.”

Lehigh Valley competed with more than 300 other communities for the investment. The region’s skilled workforce, speed to market, and location were key factors in the Fortune 100 company’s decision to build here, along with significant state support.

The Shapiro administration is investing more than $100 million, including $50 million in tax credits, a $25 million PA SITES grant for site development, and a $25 million Pennsylvania First grant.

"This is the largest economic development project in Lehigh Valley history, and it wouldn't have happened without Lilly's commitment to make products in the U.S. and the Shapiro administration's aggressive efforts for Pennsylvania to compete," Cunningham said. "It ushers in a new era of manufacturing in the Lehigh Valley, adding the production of medicines to the region's rich history of producing goods and products for the U.S. and the world."

Cunningham credited the Shapiro administration – including Secretary of Community and Economic Development Rick Siger and Chief Transformation and Opportunity Officer Ben Kirshner – for developing innovative strategies and business friendly policies that helped convince Lilly to make Lehigh Valley part of its $50 billion expansion of U.S. manufacturing.

“Without that commitment, this doesn't happen. I think I can speak on behalf of all of us in the Lehigh Valley and say thank you,” Cunningham said. “Thank you for the energy, the vision, the commitment.”

The project is part of the Shapiro administration’s PA Permit Fast Track Program, which coordinates permitting for complex economic development and infrastructure projects.

Shapiro said key permits for Lilly already have been approved significantly faster than usual. Ricks said he is hopeful that based on the pace so far, that Lilly could be producing medicines before the projected opening of 2031.

As Lilly proceeds with construction, local partners are working to build the company’s workforce, as Lilly expects 90% of the workers to be hired locally.

Lehigh Carbon Community College is playing a leading role by developing a training program for pharmaceutical and biotech workers, with up to $5 million in state funding.

"Partnering with Eli Lilly and Company represents an extraordinary opportunity for Lehigh Carbon Community College and our entire region,” said College President Dr. Ann Bieber. “The Lilly team’s remarkable vision and passion have been truly inspirational to work with.”

The new laboratory will feature state-of-the-art equipment designed to mirror the advanced manufacturing environments found in Lilly’s facilities. LCCC will renovate an existing building to create dedicated training pipelines for high-demand roles including lab testers, quality assurance technicians, manufacturing engineers, and production specialists.

“LCCC is currently developing a specialized curriculum and finalizing architectural plans for our new biotechnology center to support training for advanced manufacturing and technical roles. This partnership offers life-changing pathways for our students—delivering family-sustaining wages, career stability, and the chance to contribute to life-saving medical advancements that will benefit our local community for generations to come,” Bieber said.

Local leaders and residents are excited to welcome Lilly to Upper Macungie, the third-fastest-growing municipality in Pennsylvania over the past five years, said Jeff Fleischaker, Chair of the Upper Macungie Board of Supervisors.

"We are all looking forward to seeing what we can do, together, to make every day better in Upper Macungie," he said.

At the groundbreaking, Ricks announced Lilly will provide up to $1 million over five years to the Upper Macungie Township Community Fund to support a new quality-of-life program for Lehigh Valley families at the township's Community Lifestyle Center.

The initiative will focus on nutrition and healthy living, access to fresh food, health resources, and community programming.

“We're committed to building responsibly and to being the kind of neighbor that this community expects and deserves for the long haul,” Ricks said.

The Shapiro administration and Lehigh Valley Economic Development Corporation played leading roles in the competitive site selection process, convening local and regional partners to develop a plan to meet Lilly's infrastructure, utility, and workforce needs.

Cunningham thanked the many local and regional partners who helped bring the project to Lehigh Valley, including Upper Macungie officials; utility companies UGI, PPL, and Lehigh County Authority; property owner David Jaindl; the Lehigh Valley Planning Commission; and LCCC President Bieber and her team.

“It took a sustained, motivated local effort across many different organizations and companies to make this one of the best locations in America to win Lilly’s selection,” Cunningham said. “This type of success doesn’t happen without a lot of people working together.”

(Photo by LVEDC; rendering courtesy of Eli Lilly and Company)

Tags:Featured, Life Sciences, manufacturing, News Releases